Keywords: USA, R&D investment, PhRMA, Burrill

R&D investment by US biopharma companies reached record levels in 2010

Article | 17 March 2011

Demonstrating a steady and ongoing commitment to innovative R&D, America’s biopharmaceutical research companies invested a record $67.4 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in